Evidence map›Paper›PMID 42505191›Full record

ArticleCurrent oncology (Toronto, Ont.)2026

[

Aasa Shimizu, Tadashi Watabe, Frederik L Giesel, Yuriko Mori, Keita Asano, Yusaku Shimizu, Sadahiro Naka, Takashi Kamiya, Daisuke Katayama, Shinichiro Watanabe and 9 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Current oncology (Toronto, Ont.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Aasa ShimizuDepartment of Obstetrics and Gynecology, The University of Osaka Graduate School of Medicine, 2-2, Yamadaoka, Suita City 565-0871, Osaka, Japan.ORCID 0000-0002-2631-3182
Tadashi WatabeLaboratory for Theranostics, Division of Clinical Translation, Institute for Radiation Sciences, The University of Osaka, 1-10, Yamadaoka, Suita City 565-0871, Osaka, Japan.ORCID 0000-0001-8658-2395
Frederik L GieselDepartment of Nuclear Medicine, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Moorenstraße 5, 40225 Düsseldorf, Germany.
Yuriko MoriDepartment of Nuclear Medicine, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Moorenstraße 5, 40225 Düsseldorf, Germany.
Keita AsanoDepartment of Obstetrics and Gynecology, The University of Osaka Graduate School of Medicine, 2-2, Yamadaoka, Suita City 565-0871, Osaka, Japan.
Yusaku ShimizuDepartment of Obstetrics and Gynecology, The University of Osaka Graduate School of Medicine, 2-2, Yamadaoka, Suita City 565-0871, Osaka, Japan.
Sadahiro NakaDepartment of Pharmacy, The University of Osaka, 2-15, Yamadaoka, Suita City 565-0871, Osaka, Japan.
Takashi KamiyaDepartment of Medical Technology, The University of Osaka, 2-2, Yamadaoka, Suita City 565-0871, Osaka, Japan.
Daisuke KatayamaDepartment of Radiology, The University of Osaka Graduate School of Medicine, 2-2, Yamadaoka, Suita City 565-0871, Osaka, Japan.
Shinichiro WatanabeDepartment of Radiology, The University of Osaka Graduate School of Medicine, 2-2, Yamadaoka, Suita City 565-0871, Osaka, Japan.
Hiroki KatoDepartment of Radiology, The University of Osaka Graduate School of Medicine, 2-2, Yamadaoka, Suita City 565-0871, Osaka, Japan.
Kayako IsohashiDepartment of Radiology, The University of Osaka Graduate School of Medicine, 2-2, Yamadaoka, Suita City 565-0871, Osaka, Japan.ORCID 0000-0002-2081-3020
Mitsuaki TatsumiDepartment of Diagnostic Radiology, Juntendo University Graduate School of Medicine, 2-1-1, Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
Noriyuki TomiyamaDepartment of Radiology, The University of Osaka Graduate School of Medicine, 2-2, Yamadaoka, Suita City 565-0871, Osaka, Japan.ORCID 0000-0001-9918-7327
Yasuto KinoseDepartment of Obstetrics and Gynecology, The University of Osaka Graduate School of Medicine, 2-2, Yamadaoka, Suita City 565-0871, Osaka, Japan.ORCID 0000-0002-2910-7720
Tadashi IwamiyaDepartment of Obstetrics and Gynecology, The University of Osaka Graduate School of Medicine, 2-2, Yamadaoka, Suita City 565-0871, Osaka, Japan.
Shinya MatsuzakiDepartment of Obstetrics and Gynecology, The University of Osaka Graduate School of Medicine, 2-2, Yamadaoka, Suita City 565-0871, Osaka, Japan.ORCID 0000-0001-5725-9994
Kenjiro SawadaDepartment of Obstetrics and Gynecology, The University of Osaka Graduate School of Medicine, 2-2, Yamadaoka, Suita City 565-0871, Osaka, Japan.
Michiko KodamaDepartment of Obstetrics and Gynecology, The University of Osaka Graduate School of Medicine, 2-2, Yamadaoka, Suita City 565-0871, Osaka, Japan.ORCID 0000-0003-4046-7572

Funding

Japan Society for the Promotion of Science 23K27548Japan Society for the Promotion of Science JPJSCCA20240005
6 · The paper itself

Abstract

BACKGROUND/

objectivesAccurate preoperative assessment of peritoneal dissemination is essential in ovarian cancer because it influences surgical strategy and the achievement of complete gross resection. However, [

methodsFour patients underwent [

resultsFAPI-PET detected peritoneal dissemination not identified by FDG-PET in several cases, including occult metastasis confirmed histologically and additional lesions after neoadjuvant chemotherapy. FAPI-avid lesions showed stromal activation on immunohistochemistry, supporting the biological basis of FAPI uptake. In one case, additional FAPI uptake may have been partly influenced by inflammatory changes associated with bloody ascites.

conclusionsFAPI-PET may provide complementary information by visualizing stromal components of ovarian cancer and may support preoperative mapping of peritoneal dissemination, although interpretation should consider inflammatory conditions.

Indexed as

Ovarian NeoplasmsPeritoneal NeoplasmsPositron Emission Tomography Computed TomographyAgedFemaleFibroblast Activation Protein AlphaHumansMiddle AgedFibroblast Activation Protein Alphacancer-associated fibroblastsFAPFAPI-PETMISovarian cancer

Identifiers

PMID42505191
PMCPMC13409096

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.